Skip to content

Secant Group

Secant Group is a Pennsylvania-based biomaterials company that engineers advanced textiles, polymers, and hybrids for implantable medical devices and pharmaceuticals.

Last updated September 27, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Secant Group is an American biomaterials company headquartered in Telford, Pennsylvania, with additional manufacturing sites in Quakertown and Perkasie, Pennsylvania. The company describes itself as a leader in biomaterials expertise and a partner in textiles design, developing textiles, polymers, and hybrids at scale for the medical device and pharmaceutical industries. Its stated vision is to be an innovator in the development and transformation of biomaterials that restore the body, and its mission is to engineer biomaterials that facilitate the repair, recovery, and regeneration of the human body. Secant serves medical device applications across cardiovascular, general surgery, orthopedic, and neurovascular fields. It offers product engineering, prototype design, and manufacturing services, and works with customers from R&D and initial concept through scale-up. The company also develops next-generation technologies such as drug delivery and tissue engineering, integrating advanced polymers with leading innovators to enhance patient solutions. Its service model emphasizes quality, scalability, reliability, rapid response, transparent communication, and continuous improvement. Secant operates from more than 150,000 square feet of facility space. Its headquarters is at 551 E Church Ave in Telford, PA, with manufacturing sites at 195 O'Neill Drive in Quakertown, PA, and 430 S 8th Street in Perkasie, PA. The company is part of the Solesis family of companies, working alongside sister companies Polyzen, SanaVita Medical, and Charter Medical to provide advanced textiles, polymers, and hybrids to life science companies. Through integrated research and development activities, the group helps bring new technologies and therapies to market. As a corporate brand, Secant Group is positioned as a business-to-business partner for medical device and pharmaceutical innovators rather than a consumer-facing brand. Its public communications emphasize collaboration, ethical conduct, technical expertise, and the goal of making life-changing therapies more accessible to more patients. The company's identity is closely tied to the broader Solesis platform, which unifies several complementary life science manufacturing and development businesses.

History

Secant Group is a United States-based biomaterials company located in Telford, Pennsylvania. Public information about the company's early corporate history is limited, but its current identity is closely tied to its role as a developer and manufacturer of advanced textiles, polymers, and hybrids for the medical device and pharmaceutical industries. The company operates from more than 150,000 square feet of facility space, including its headquarters at 551 E Church Ave in Telford, PA, and manufacturing sites at 195 O'Neill Drive in Quakertown, PA, and 430 S 8th Street in Perkasie, PA. Secant Group is part of the Solesis family of companies, alongside sister companies Polyzen, SanaVita Medical, and Charter Medical. This group structure allows Secant to work closely with complementary life science businesses, providing advanced textiles, polymers, and hybrids to life science companies. Through integrated research and development activities across the group, Secant helps bring new technologies and therapies to market. The company's public positioning centers on biomaterials innovation for implantable medical devices. It serves applications in cardiovascular, general surgery, orthopedic, and neurovascular fields, and offers services spanning product engineering, prototype design, and manufacturing. Secant also develops next-generation technologies such as drug delivery and tissue engineering, integrating advanced polymers with leading innovators to enhance patient solutions. Its stated vision is to be an innovator in the development and transformation of biomaterials that restore the body, and its mission is to engineer biomaterials that facilitate the repair, recovery, and regeneration of the human body. While specific founding dates, founders, and ownership changes are not provided in the available evidence, Secant Group's current operations reflect a focus on quality, scalability, reliability, rapid response, transparent communication, and continuous improvement. The company emphasizes a culture of teamwork, collaboration, and ethical conduct in its pursuit of results. As a subsidiary within the Solesis group, Secant continues to operate as a business-to-business partner for medical device and pharmaceutical innovators.

Products and positioning

A business-to-business biomaterials partner for medical device and pharmaceutical innovators, emphasizing quality, scalability, and integrated R&D within the Solesis family of companies.

  • Implantable medical textiles and fabrics

    Advanced textiles designed for implantable medical device applications.

  • Advanced polymers

    Polymers developed and integrated for next-generation healthcare innovations.

  • Textile-polymer hybrids

    Hybrid materials combining textiles and polymers for medical devices.

  • Drug delivery materials

    Next-generation technologies for drug delivery applications.

  • Tissue engineering materials

    Biomaterials for tissue engineering applications.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/secant-group-united-states · Editorial policy · How profiles are compiled